Letybo®
Botulinum Toxin Type Α – 50 units of powder for solution for injection.
The product is intended for use by healthcare professionals only
Adverse Event Reporting
Adverse events must be reported to Croma-Pharma GmbH, email: [email protected]Report ALL side effects for ALL medications to: National Medicines Agency Mesogeion 284 GR-15562 Cholargos, Αthens Τel: +30 213 2040380/337 Website: http://www.eof.gr http://www.kitrinikarta.gr
